Clinical trials show progress in migraine frequency, skin cancer prevention

-
1:50
Schlesinger’s Saturday Showcase...Cars, comic books, maple...
-
3:10
Temperatures on the rebound for the upcoming week, few precip...
-
1:13
Megill ready to close his way
-
2:25
West Allis Central High School cheerleaders make history
-
3:04
MPD officers have not undergone required SRO training ahead of...
-
2:38
Dodge Co. Sheriff calls Evers prison plan ’seriously flawed’
-
2:50
Brewers’ announcers exclusive without Uecker
-
1:47
Brief school closures considered amid MPS lead exposure concerns
-
1:21
5th annual Have Heart fundraiser held at Waukesha West High School
-
2:36
Gold Glove winner Turang preps for 2nd and short
-
2:22
Trial for homicide of 5-year-old Prince McCree set in June as...
-
1:58
Blow off steam at Bust-N-Stuff, Wisconsin’s longest-running...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.